Humans are inherently social beings who thrive on making and maintaining social relationships. Connecting with and supporting one another forms deep bonds that make us feel seen, valued, and like we belong. These social interactions are not only important for our emotional well-being but also for our physical well-being—maybe even more so than originally thought. Loneliness, an increasingly prevalent global public health issue, has been linked to serious health risks, including dementia.
Below, we take a closer look into the link between loneliness and dementia, how loneliness affects brain health, and loneliness and social isolation as a modifiable risk factor for dementia.
In a recent study published in Neurology, a peer-reviewed neurology journal, in February of 2022, researchers revealed a shockingly robust link between loneliness and dementia, bolstering previous studies. Key findings of this study include the following:
Previous research has shown similar (yet slightly different) findings. A 2007 study assessing loneliness and the risk of Alzheimer’s disease, the most common cause of dementia, found that Alzheimer’s risk was more than doubled in lonely individuals compared to those who were not lonely. Results from a 2019 study indicated that loneliness was associated with a 40% increased risk of dementia.
As a whole, this research suggests that loneliness may either be an early symptom of neurodegenerative diseases or an early contributor to neuropathy and cognitive decline. In other words, it is not yet clear if loneliness is a consequence or risk factor/cause of dementia.
Whether loneliness stems from living alone, the loss of a loved one, chronic illness, sensory impairments, or even social isolation due to the COVID-19 pandemic, it has a strong impact on brain health—but what is it about loneliness that affects brain health and causes this increased dementia risk?
Loneliness can result in several circumstances and conditions that can ultimately contribute to cognitive decline and increased dementia risk. These conditions include social isolation, lack of brain stimulation, increased levels of stress, poor sleep, and mental health disorders, all of which have been linked to cognitive decline and an increased risk of developing dementia. Poor social relationships have also been associated with an increased risk of vascular conditions, such as heart disease and stroke, which are known risk factors for dementia.
This research sheds light on a robust link between loneliness and dementia, emphasizing the importance of understanding our brain health as we age and addressing modifiable risk factors for dementia. Recognizing and addressing signs of loneliness in ourselves as well as our loved ones and prioritizing our brain health can go a long way.
Just as we regularly get checked for things like high blood pressure, heart disease, and cancer, we should be regularly checked for changes in brain health. This is particularly true for individuals with known risk factors for developing Alzheimer’s disease or other causes of dementia, including loneliness and social isolation. Identifying risk factors and detecting changes in brain health as early as possible is key to delaying or even preventing cognitive decline.
At Altoida, we are dedicated to providing a reliable, affordable, and accessible way to measure and monitor brain health. We are building the world’s-first Precision Neurology platform and app-based medical device—backed by 11 years of clinical validation—to accelerate and improve drug development, neurological disease research, and patient care.
By completing a 10-minute series of augmented reality and motor activities designed to simulate complex Activities of Daily Living on a smartphone or tablet, Altoida’s device extracts and provides robust measurements of neurocognitive function across 13 neurocognitive domains. Our device measures and analyzes nearly 800 multimodal cognitive and functional digital biomarkers. Through the collection of highly granular data from integrated smartphone or tablet sensors, Altoida’s device produces comprehensive neurocognitive domain scores. This data can be tracked longitudinally to reveal trends and patterns while flagging concerning ones.
This method, along with our innovative artificial intelligence, will pioneer fully digital predictive neurological disease diagnosis. After our Breakthrough Device designation by the FDA, Altoida’s device will provide patients with a predictive score that will enable a highly accurate prediction of whether a patient aged 55 and older will or will not convert from Mild Cognitive Impairment to Alzheimer’s disease. In the future, we hope to utilize our technology to diagnose a breadth of neurological diseases.
To learn more about the link between loneliness and dementia or about Altoida’s Precision Neurology platform, contact us today.